Doctor’s Stage 4 Cancer Diagnosis Sparks Urgent Awareness Campaign

A routine visit to his family physician led emergency physician Terrence May to a life-altering diagnosis: Stage 4 cancer. May, an active individual who enjoys running, cycling, and hockey, began noticing alarming symptoms last spring. He experienced unusual fatigue during runs, significant weight loss, and abdominal pain. After undergoing imaging, he learned he had intrahepatic bile duct cancer, also known as cholangiocarcinoma, a rare and aggressive form of cancer.

According to the Canadian Cancer Society, approximately 600 Canadians are diagnosed with cholangiocarcinoma each year. The prognosis is grim; only 9 percent of patients survive five years after diagnosis, primarily because the disease is often detected at an advanced stage. May underwent molecular testing facilitated by the Canadian Cholangiocarcinoma Collaborative but ultimately stopped treatment due to the palliative nature of his diagnosis. He emphasized the importance of spending quality time with his loved ones during this challenging period.

Impact of Cholangiocarcinoma on Families

The story of Andrea Katz and her mother, Joanne Katz, mirrors May’s experience. In 2013, Joanne, who was 67, began to suffer from unexplained weight loss and discomfort. After several tests and misdiagnoses, she was finally diagnosed with cholangiocarcinoma. Initially given a year to live, her condition deteriorated rapidly, leading to her passing just 44 days after her diagnosis.

Now a digestive health nutritionist, Andrea reflects on her mother’s case and stresses the critical need for early detection and medical attention. “I often think about whether there were signs we missed that could have led to an earlier diagnosis,” she said. She urges others to pay close attention to their bodies and seek help when necessary.

Rising Cases and Limited Treatment Options

Cholangiocarcinoma is the second most common liver cancer, with most patients diagnosed at Stage 4, when surgical options are no longer viable. Dr. Arndt Vogel, an oncologist at the Princess Margaret Cancer Centre in Toronto, notes that while treatment options exist, many are not available in Canada, particularly targeted therapies. He expressed concern about the increasing number of younger patients affected by this cancer.

“The prognosis remains poor, and the available treatments are not accessible for many patients,” Dr. Vogel stated. He advocates for greater awareness and faster adaptation of treatment approvals in Canada, emphasizing the need for urgent progress.

Despite his challenges, May remains committed to raising awareness and advocating for cholangiocarcinoma research. In June, he organized a 5K run in his hometown of Lakefield, Ontario, which raised over $130,000 for research initiatives. “When you hear that word cholangiocarcinoma, it’s crucial to advocate for yourself,” he said, underscoring the importance of proactive health management.

The stories of both May and Katz highlight the urgent need for better awareness, early detection, and improved treatment options for cholangiocarcinoma. As more individuals face this devastating diagnosis, their experiences underline the importance of listening to one’s body and seeking timely medical intervention.